Comparison of Trans-Viginal Tape (TVT) and Trans-Obturator (TOT) Tape Methods for Management of Stress Urinary Incontinence among Women with Post-Menopausal Condition
Abstract
Objective To compare the frequency of success of TVT versus TOT for SUI in postmenopausal women.
Methodology: A randomized control trial study was conducted at department of Urology, Sharif Institute of Urology and Renal Transplant, Lahore from 11-07-2019 to 10-01-2020. Females of postmenopausal age presenting with stress urinary were included in the study however, the patients with bleeding diathesis, untreated urinary tract infection. Diabetes and chronic kidney diseases were excluded from study. Patients were divided into two groups (A &B) after taken an informed consent. In group A, patients underwent TVT and in group B, patients underwent TOT. After 3 months, patients were evaluated for symptoms of stress urinary incontinence and stress test. Both groups were compared by using chi-square test for desired outcome with p value ≤ 0.05 as significant.
Results: Mean durations of menopause were 10.94±3.91 and 6.75±1.05 years and mean duration of symptoms were 6.42±2.94 and 7.39±1.82 years in groups A and B, respectively. Majority of patients were married i.e. 66.0% and 74.0% and sexually inactive i.e. 88.0% and 94.0%, in groups A and B, respectively. Successful treatment was observed in 70.0% patients after TVT procedure and 94.0% patients after TOT procedure (p-value= 0.002).
Conclusion: Higher success rates were observed in postmenopausal women of < 50 and > 70 years of age, underweight and normal weight women, unmarried, sexually inactive, women with less than 5 years of Duration of menopause and less than 5 years of duration of symptoms of urinary stress incontinence. Objective: To determine the impact of midlife on professional life by exploring the workplace challenges faced by women
Copyright (c) 2025 Journal of The Society of Obstetricians and Gynaecologists of Pakistan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.